2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$187.15+$5.59 (+3.08%)
Price as of Jun 23, 2026 1:42 PM EDT- $8.7BMarket Cap
- 23.19%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$187.15+$5.59 (+3.08%)
CRL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $181.56 | ||
Change | -$3.44 (-1.86%) | ||
Open | $183.51 | ||
High | $186.30 | ||
Low | $178.92 | ||
Previous Close | $185.00 | ||
Volume | 670,146 | ||
30-Day Average Volume | 829,653 | ||
1-Week Change | -3.67% | ||
1-Month Change | 13.26% | ||
1-Year Change | 23.19% | ||
3-Year Change | -11.07% | ||
5-Year Change | -50.12% | ||
Fundamentals | |||
Shares Outstanding | 48.2M | ||
Total Assets | $7.7B | ||
Market Cap | $8.7B | ||
Enterprise Value | $11.2B | ||
Period: QTR TTM FY | |||
Revenue | $798.2M | ||
Net Income | -$14.8M | ||
Free Cash Flow | -$14.8M | ||
EBIT | -$30.0M | ||
EBITDA | $37.2M | ||
Net Working Capital | $395.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | 302 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 3 | ||
P/E | -605 | ||
PEG | -6 | ||
Price/Free Cash Flow | -590 | ||
Price/Operating Cash Flow | 213 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue